Expert Review of Cardiovascular Therapy provides expert reviews on the clinical applications of new medicines, therapeutic agents and diagnostics in cardiovascular disease. Coverage includes drug therapy, heart disease, vascular disorders, hypertension, cholesterol in cardiovascular disease, stroke, heart failure and cardiovascular surgery.
The journal adopts the unique Expert Review article format, offering a complete overview of current thinking in a key technology area, research or clinical practice, augmented by the following sections:
Expert commentary - a personal view on the most effective or promising strategies; Five-year view - a clear perspective of future prospects within a realistic time scale; Key issues - an executive summary cutting to the author's most critical points
Articles are subject to peer-review by three independent referees on a double-blind basis. Authors publishing in the journal are asked to disclose any professional or financial interest that may be perceived as causing a conflict of interest in the context of the article.
The journal welcomes unsolicited review proposals.
